Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV004797611 | SCV005419044 | uncertain significance | Pitt-Hopkins syndrome | 2024-08-30 | reviewed by expert panel | curation | The p.Ser198= variant in TCF4 is absent from gnomAD v4.1 (PM2_Supporting). The p.Ser198= variant is observed in at least 1 unaffected individual (internal database - GeneDx) (BS2_Supporting). The p.Ser198= variant is found in a patient with an alternate molecular basis of disease (internal database - GeneDx) (BP5). The silent p.Ser198= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Ser198= variant in TCF4 is classified as Uncertain significance based on the ACMG/AMP criteria (PM2_Supporting, BS2_Supporting, BP5, BP7). |
Gene |
RCV000444889 | SCV000522574 | likely benign | not specified | 2015-12-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000726870 | SCV000703748 | uncertain significance | not provided | 2017-01-13 | criteria provided, single submitter | clinical testing |